General Information of the Protein
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000027 , tsA201
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Voltage-gated calcium channel alpha Cav3.1 (CACNA1G) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 5 Target-related Diseases | 5 | |||
| 1 | Epilepsy [ICD-11: 8A60-8A68] | ||||
| 2 | Schizophrenia [ICD-11: 6A20] | ||||
| 3 | Pancreatic cancer [ICD-11: 2C10] | ||||
| 4 | Hypertension [ICD-11: BA00-BA04] | ||||
| 5 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
| Approved Drug(s) | 4 Approved Drugs | 4 | |||
| 1 | Ethosuximide | Approved | |||
| 2 | Penfluridol | Approved | |||
| 3 | Trimethadione | Approved | |||
| 4 | Verapamil | Approved | |||
| Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
| 1 | NGD 94-1 | Phase 1 | |||
| Investigative Drug(s) | 1 Investigative Drug | 1 | |||
| 1 | KYS-05050 | Investigative | |||
Similar Protein(s) and Bioactivity Statistics
50% Identity
| Protein ID | Protein Name | Protein Organism | |
| PT00592 | T-type calcium channel alpha 1G subunit | Mus musculus, Mouse | |
|---|---|---|---|